GenSight Biologics S.A. logo

GenSight Biologics S.A.

EPA:SIGHT.PA

Overview | Financials
Company Name GenSight Biologics S.A.
Symbol SIGHT.PA
Currency EUR
Price 0.37
Market Cap 40,439,101
Dividend Yield 0%
52-week-range 0.282 - 0.919
Industry Biotechnology
Sector Healthcare
CEO Dr. Bernard Gilly Ph.D.
Website https://www.gensight-biologics.com

An error occurred while fetching data.

About GenSight Biologics S.A.

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010),

Related Stocks

Fermentalg SA logo

Fermentalg SA

FALG.PA

0.56 EUR

Eurofins-Cerep SA logo

Eurofins-Cerep SA

ALECR.PA

21,200 EUR

Sequana Medical NV logo

Sequana Medical NV

SEQUA.BR

0.926 EUR

MDxHealth SA logo

MDxHealth SA

MDXH.BR

3.02 EUR

MaaT Pharma SA logo

MaaT Pharma SA

MAAT.PA

7.34 EUR

Novacyt S.A. logo

Novacyt S.A.

ALNOV.PA

0.984 EUR

OSE Immunotherapeutics SA logo

OSE Immunotherapeutics SA

OSE.PA

8.51 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD